Find the BEST weed in...
New Federal Proposal Aims to Track How Much Medicaid Is Spending on Cannabis-Related Care
Apr 23, 2026
Source:
TG Branfalt
Ganjapreneur
The push for more oversight on how federal money intersects with our community continues to ramp up on Capitol Hill. Senator Ted Budd from North Carolina recently introduced a new piece of legislation called the Marijuana Impact on Medicaid Act. If passed, this bill would task the Secretary of Health and Human Services with a very specific mission: tracking every cent of Medicaid funding spent on healthcare services linked to cannabis use, ranging from standard outpatient check-ups to emergency room visits.
This move comes at a pretty interesting time for the industry. Just weeks ago, we saw the rollout of a historic Medicare pilot program that actually allows some providers to get reimbursed for recommending and providing specific hemp-based CBD products. While that felt like a massive step toward mainstream acceptance, Senator Budd’s bill highlights that there is still plenty of skepticism in the halls of Congress. He argues that lawmakers are flying blind without hard data on how cannabis affects public health and federal budgets, especially for the millions of people relying on Medicaid.
Unsurprisingly, the bill has found a major ally in the anti-cannabis group Smart Approaches to Marijuana. They’re even currently in the middle of a legal battle to shut down that same Medicare CBD pilot program we’ve been watching. They view this new legislation as a necessary way to account for the costs of what they call the normalization of the plant.
So, why does this matter for the everyday enthusiast? It’s a reminder that as we move toward rescheduling and broader access, the debate over how we integrate cannabis into the national healthcare system is only getting started. While more data is generally a good thing for transparency, the intent behind this specific collection effort is clearly focused on highlighting potential negatives. As always, the best way to stay ahead of the curve is to keep supporting high-quality, lab-tested products and staying informed on how these federal shifts might eventually touch your local scene.







